The US withdrew from treaty negotiations on President Trump’s first day in office.
Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and effective drugs.
Many claims about the dangers of vaccines come from misrepresenting scientific research papers.
Both Trump and Harris seek to lower drug costs for patients. What headway have they made on realizing this goal?
Horseshoe crabs play a unique role in medicine, but they’re also ecologically important in their home waters along the Atlantic coast. Can regulators balance the needs of humans and nature?
An anthropology course explores how peoples and cultures around the world use nature-based medicines to heal.
If no action is taken to address antibiotic resistance, infections from multidrug-resistant bacteria could cause 10 million deaths each year by 2050.
New payment models may mean more of the people who need these treatments can get them.
COVID-19 has exacerbated a backlog of domestic and foreign drug manufacturing inspections that the FDA is still too short-staffed to adequately deal with.
'Orphan drugs' with high price points are being tested as treatments for COVID-19. There's a better way to spur low-cost innovation for new drugs.
/
2
